Thomas A MCCOURT sold $245k of IRWD
Chief Executive Officer at IRONWOOD PHARMACEUTICALS INC. 139,064 shares at an average of $1.76, traded Feb 10, 2025, filed Feb 12, 2025.
Score components
- +25RoleCEO
- +13Trade size$245k at market
- +5Share of holdings soldSold 11% of holdings
- +15Cluster5 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-019237, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 10, 2025 | SOpen-market sale Class A Common Stock | -139,064 | $1.76 | $245k | 1,160,634 | Feb 12, 2025 |
Related signals
Other insiders at IRONWOOD PHARMACEUTICALS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | IRONWOOD PHARMACEUTICALS INC | Tammi L Gaskins Chief Commercial Officer | $1,487 2,563 shares | -1% | |
| 33Weak | IRONWOOD PHARMACEUTICALS INC | Thomas A MCCOURT Chief Executive Officer | $7,745 13,353 shares | -1% | |
| 37Weak | IRONWOOD PHARMACEUTICALS INC | Gregory S. Martini Chief Financial Officer | $21k 12,052 shares | -6% | |
| 38Weak | IRONWOOD PHARMACEUTICALS INC | Minardo John Chief Legal Officer | $69k 38,938 shares | -9% | |
| 38Weak | IRONWOOD PHARMACEUTICALS INC | Michael Shetzline SVP, CMO, Head-Res&Drug | $73k 41,269 shares | -7% | |
| 30Weak | IRONWOOD PHARMACEUTICALS INC | Ronald Silver Principal Accounting Officer | $21k 12,048 shares | -4% | |
| 23Weak | IRONWOOD PHARMACEUTICALS INC | Andrew Davis SVP, Chief Business Officer | $22k 5,360 shares | -2% | |
| 36Weak | IRONWOOD PHARMACEUTICALS INC | Sravan Kumar Emany SVP, COO and CFO | $45k 11,001 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.